| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tyra Biosciences, Inc. | Director | Common Stock | 28.2K | $276K | $9.78 | Jun 18, 2025 | Direct |
| Avalo Therapeutics, Inc. | Director | Restricted Stock Units | 6.33K | $53.6K | $8.46 | Mar 28, 2025 | Direct |
| Avalo Therapeutics, Inc. | Director | Common Stock | 3.17K | $26.8K | $8.46 | Mar 28, 2025 | Direct |
| Tyra Biosciences, Inc. | Director | Stock Option (Right to Buy) | 22.2K | May 29, 2025 | Direct | ||
| Avalo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20.1K | Jun 17, 2025 | Direct |